Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Preferred Dividend Payments: 2022-2024

Historic Preferred Dividend Payments for Fortress Biotech (FBIO) over the last 3 years, with Dec 2024 value amounting to $9.9 million.

  • Fortress Biotech's Preferred Dividend Payments rose 0.05% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 2.76%. This contributed to the annual value of $9.9 million for FY2024, which is 23.17% up from last year.
  • As of FY2024, Fortress Biotech's Preferred Dividend Payments stood at $9.9 million, which was up 23.17% from $8.0 million recorded in FY2023.
  • Fortress Biotech's Preferred Dividend Payments' 5-year high stood at $9.9 million during FY2024, with a 5-year trough of $8.0 million in FY2022.
  • Moreover, its 3-year median value for Preferred Dividend Payments was $8.0 million (2023), whereas its average is $8.7 million.
  • Data for Fortress Biotech's Preferred Dividend Payments shows a peak YoY climbed of 23.17% (in 2024) over the last 5 years.
  • Over the past 3 years, Fortress Biotech's Preferred Dividend Payments (Yearly) stood at $8.0 million in 2022, then remained steady at $8.0 million in 2023, then rose by 23.17% to $9.9 million in 2024.